BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, June 22, 2026
Home » SARS-CoV-2

Articles Tagged with ''SARS-CoV-2''

Other news to note for Jan. 6, 2021

Jan. 6, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advanced Oncotherapy, Apex Family Medical, Bioclinica, Biodesix, Bio-Techne, Biotheranostics, Bioventrix, Carmat, Change Healthcare, Cssi Lifesciences, Diamedcare, Fathom Consulting, Fresenius Kabi, Helix Opco, Helius Medical Technologies, Hologic, Illumina, Medacuity, Monteris Medical, Nephros, Novasep, Optimuminsight, Pointclickcare, Rewalk Robotics, Saliency, Sartorius, Scaleready, Seegene, Sequans Communications, Skylight Health, Tonic Bioventures, Withings, Valgenesis.
Read More

Moderna’s COVID-19 vaccine second to clear EMA approval

Jan. 6, 2021
By Nuala Moran
LONDON – The EMA has recommended approval of Moderna Inc.’s COVID-19 vaccine, becoming the fourth western regulator to do so, after Israel approved the product on Jan. 5 and the FDA and Health Canada in December.
Read More
2020 pandemic illustration

2020 Year in Review: Biopharma vs. COVID-19

Jan. 5, 2021
Thanks to the pandemic caused by the SARS-CoV-2 coronavirus identified in late December 2019, 2020 was the year of COVID-19. It was a year of lockdowns and social distancing, a year of Zoom meetings and virtual conferences, and a year when donning a face mask sometimes came to signify a political rather than health decision.
Read More
Coronavirus mutation illustration
Mask up

COVID anniversary coincides with advent of more transmissible variants

Jan. 5, 2021
By Anette Breindl
It has been a year since Wuhan health authorities first issued a bulletin about a cluster of pneumonia cases of unknown cause, first bringing what would become the COVID-19 pandemic to the attention of the World Health Organization. Now, a mutation that significantly increases SARS-CoV-2’s transmissibility has been detected in the U.S. 
Read More
Vaccine administration

Change to COVID-19 vaccine dosing schedule stirs debate

Jan. 5, 2021
By Nuala Moran
LONDON – Controversy has erupted over COVID-19 vaccines dosing after the U.K. said it is to prioritize giving as many people as possible a single dose of the two currently approved products, rather than two doses three or four weeks apart, as scheduled on their labels. The move prompted a sharp rebuke from FDA Commissioner Stephen Hahn and Peter Marks, director of FDA’s Center for Biologics Evaluation, who said any such change “is not rooted in the science.”
Read More

Regulatory front for Jan. 5, 2021

Jan. 5, 2021
By Mark McCarty
The latest global regulatory news, changes and updates affecting medical devices and technologies, including: GAO says wound care spending dropped between 2016 and 2018; FDA updates COVID testing data; May 2019 Q-sub guidance appears in final form.
Read More

Regulatory actions for Jan. 5, 2021

Jan. 5, 2021
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Accuray, Bioserenity, Nirmidas Biotech, Spark Biomedical, Trinity Biotech.
Read More

Other news to note for Jan. 5, 2021

Jan. 5, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Airstrip, Annar Health Technologies, Anthem, Aspen Laser Systems, Balt USA, Biotricity, Blue Earth Diagnostics, Bruker, Byte, Capsule Technologies, Coopersurgical, Curetis, Dentsply Sirona, Durect, Dxterity Diagnostics, Embryo Options, Emmes Company, Evonik, Evosep, Exact Sciences, Facedrive, Hanuman Pelican, Healthcore, Icecure Medical, Impulse Dynamics, Medx, Microvention, Neoteryx, Neox, Novamed, Nxt-ID, Nyxoah, Opgen, Ortho Regenerative Technologies, Perspectum, Premier, Protech, Redox, Retia Medical, Saphena, Scintomics, Sera Prognostics, Simplivia Healthcare, Terumo, Thrive Earlier Detection, Trice Imaging, University of Birmingham, Vibrent Health, Withings.
Read More
Coronavirus vaccine/therapeutics illustration

Rising vaccine access, but research remains vigilant as SARS-CoV-2 mutates

Jan. 5, 2021
By Karen Carey
Relief spread across the world in December when the first two mRNA COVID-19 vaccines received emergency use approvals, although that deep sigh was short-lived as a highly-transmissible SARS-COV-2 mutation began to make its rounds, highlighting the need for continued research to strengthen the arsenal.
Read More

Regulatory front for Jan. 4, 2021

Jan. 4, 2021
By Mark McCarty
The latest global regulatory news, changes and updates affecting medical devices and technologies, including: FDA: Curative test for COVID should be conducted per product label; FDA posts MEA final guidance; CMS eyes radiology quality measures; Ra Medical agrees to fines.
Read More
Previous 1 2 … 73 74 75 76 77 78 79 80 81 … 136 137 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 22, 2026.
  • Alicorn synthesizes new AAK1 inhibitors

    BioWorld Science
    Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
  • Illustration of glucose in the blood stream

    CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research

    BioWorld Science
    Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
  • Illustration of a child's brain

    Saniona reports preclinical data for SAN-2668

    BioWorld Science
    Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
  • CC-3 antibody shows antitumoral activity in penile cancer

    BioWorld Science
    Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing